LigaTrap Technologies is an innovative North Carolina biotechnology company offering a unique suite of proprietary technologies used in the purification of proteins. We specialize in the purification of antibodies and viruses in the bioprocessing industry for antibody-based medications, viral vaccines, and gene therapy. With products proven to be technologically and economically superior to commercial counterparts based on both internal and external testing.
We offer a range of high-quality purification solutions in a number of formats to best fit our customers’ needs. Our portfolio includes LigaTrap’s novel LigaGuard technology, that is specially designed to purify host cell proteins from bioprocessing for mammalian samples and viruses, as well as our newly introduced AAVidity resin – that purifies Adeno-associated viruses from HEK293 and Sf9 lysate applications.